Dr.Uma Borate The Ohio State University / James Cancer Hospital
@beatalleukemia.bsky.social
Clonal Hematopoesis,MDS,AML @OSUCCC_James Acute Leukemia Clinical Section Head and Clinical Research Director. Girl Mom, Vegetarian, Avid Reader, Traveller & Adventurer
How fortunate are we to have @kimrynrathmell.bsky.social
bring her wealth of experience & outstanding leadership to @osucccjames.bsky.social
@osuwexmed.bsky.social ! Welcome to #BuckeyeNation Dr. Rathmell! @osuhematology.bsky.social
bring her wealth of experience & outstanding leadership to @osucccjames.bsky.social
@osuwexmed.bsky.social ! Welcome to #BuckeyeNation Dr. Rathmell! @osuhematology.bsky.social
April 24, 2025 at 12:20 PM
How fortunate are we to have @kimrynrathmell.bsky.social
bring her wealth of experience & outstanding leadership to @osucccjames.bsky.social
@osuwexmed.bsky.social ! Welcome to #BuckeyeNation Dr. Rathmell! @osuhematology.bsky.social
bring her wealth of experience & outstanding leadership to @osucccjames.bsky.social
@osuwexmed.bsky.social ! Welcome to #BuckeyeNation Dr. Rathmell! @osuhematology.bsky.social
The closest I’m ever going to come to a National Football Championship Trophy ! 🙏🏽 @Peletonia @Huntington_Bank @OhioStateFB Proud to be a Peletonia funded @osuhematology.bsky.social @osucccjames.bsky.social Researcher & part of #BuckeyeNation
April 10, 2025 at 12:47 AM
The closest I’m ever going to come to a National Football Championship Trophy ! 🙏🏽 @Peletonia @Huntington_Bank @OhioStateFB Proud to be a Peletonia funded @osuhematology.bsky.social @osucccjames.bsky.social Researcher & part of #BuckeyeNation
What other kinds of presentations are there (other than fabulous ? ) Clearly, I have been attending the wrong conferences so far without fabulous presentations 😂
April 9, 2025 at 1:41 AM
What other kinds of presentations are there (other than fabulous ? ) Clearly, I have been attending the wrong conferences so far without fabulous presentations 😂
Reposted by Dr.Uma Borate The Ohio State University / James Cancer Hospital
a nice analysis from the BEAT AML study outlining molecular characteristics of adults >60 with AML
www.nature.com/articles/s41...
www.nature.com/articles/s41...
April 6, 2025 at 2:05 PM
a nice analysis from the BEAT AML study outlining molecular characteristics of adults >60 with AML
www.nature.com/articles/s41...
www.nature.com/articles/s41...
Reposted by Dr.Uma Borate The Ohio State University / James Cancer Hospital
Hi.
Books are incredibly important.
Please let them be.
Books are incredibly important.
Please let them be.
April 6, 2025 at 9:04 PM
Hi.
Books are incredibly important.
Please let them be.
Books are incredibly important.
Please let them be.
Reposted by Dr.Uma Borate The Ohio State University / James Cancer Hospital
helpful sub-group analysis of Aza + Ven studies looking at treatment-naive t-AML and AML arising from MDS or CMML!
www.nature.com/articles/s41...
www.nature.com/articles/s41...
April 2, 2025 at 5:56 PM
helpful sub-group analysis of Aza + Ven studies looking at treatment-naive t-AML and AML arising from MDS or CMML!
www.nature.com/articles/s41...
www.nature.com/articles/s41...
Very proud to have played a role in this study with my study chair Dr. Eric Huselton from University of Rochester - please consider your patients for this study @osuhematology.bsky.social @osucccjames.bsky.social @swog.org @ash.hematology.org
#myeloMATCH sub-study MM1OA-S03 is open!
Patients registered to MYELOMATCH screening protocol who are 60+ or unfit for chemo and have AML w an IDH2 gene mutation may be assigned. Randomized to venetoclax + ASTX727 w/wo enasidenib.
swog.org/clinical-trials/MM1OA-S03 @beatalleukemia.bsky.social
Patients registered to MYELOMATCH screening protocol who are 60+ or unfit for chemo and have AML w an IDH2 gene mutation may be assigned. Randomized to venetoclax + ASTX727 w/wo enasidenib.
swog.org/clinical-trials/MM1OA-S03 @beatalleukemia.bsky.social
April 2, 2025 at 7:18 PM
Very proud to have played a role in this study with my study chair Dr. Eric Huselton from University of Rochester - please consider your patients for this study @osuhematology.bsky.social @osucccjames.bsky.social @swog.org @ash.hematology.org
Reposted by Dr.Uma Borate The Ohio State University / James Cancer Hospital
If you know anyone that takes Sprycell, please let them know !!!
🚨 𝐌𝐀𝐒𝐒𝐈𝐕𝐄 𝐏𝐑𝐈𝐂𝐄 𝐃𝐑𝐎𝐏! 📢
We just dropped the price of all Dasatinib strengths by over 90% on costplusdrugs.com!
Why? Because our pricing model is simple:
When we get a lower price, you get a lower price.
🔗 www.costplusdrugs.com/medications/...
We just dropped the price of all Dasatinib strengths by over 90% on costplusdrugs.com!
Why? Because our pricing model is simple:
When we get a lower price, you get a lower price.
🔗 www.costplusdrugs.com/medications/...
March 28, 2025 at 8:01 PM
If you know anyone that takes Sprycell, please let them know !!!
Reposted by Dr.Uma Borate The Ohio State University / James Cancer Hospital
A great @bloodjournal.bsky.social paper by @beatalleukemia.bsky.social et al on clinical trial eligibility for patients with MDS!
ashpublications.org/blood/articl...
ashpublications.org/blood/articl...
March 28, 2025 at 3:34 PM
A great @bloodjournal.bsky.social paper by @beatalleukemia.bsky.social et al on clinical trial eligibility for patients with MDS!
ashpublications.org/blood/articl...
ashpublications.org/blood/articl...
Thrilled to see our effort on behalf of @ic_MDS group out in @BloodJournal about reducing clinical trial eligibility barriers for our MDS patients. Commentary by Lionel Ades on ‘ releasing the brake’ on eligibility criteria. @Dr_AmerZeidan #mdssm ashpublications.org/blood/article/…
March 28, 2025 at 3:25 PM
Thrilled to see our effort on behalf of @ic_MDS group out in @BloodJournal about reducing clinical trial eligibility barriers for our MDS patients. Commentary by Lionel Ades on ‘ releasing the brake’ on eligibility criteria. @Dr_AmerZeidan #mdssm ashpublications.org/blood/article/…
Reposted by Dr.Uma Borate The Ohio State University / James Cancer Hospital
Happy CD3 CD28 T Cell Stimulation Day to all who celebrate
March 28, 2025 at 11:34 AM
Happy CD3 CD28 T Cell Stimulation Day to all who celebrate
Calling all hematologists - how are you interpreting the results of the TRAIN trial vs the SAHARA trial in patients with blood cancers & acute cerebral bleeding events ?
jamanetwork.com/journals/jam...
www.nejm.org/doi/full/10....
@shematologist.medsky.social @bloodman.bsky.social
jamanetwork.com/journals/jam...
www.nejm.org/doi/full/10....
@shematologist.medsky.social @bloodman.bsky.social
March 26, 2025 at 4:16 PM
Calling all hematologists - how are you interpreting the results of the TRAIN trial vs the SAHARA trial in patients with blood cancers & acute cerebral bleeding events ?
jamanetwork.com/journals/jam...
www.nejm.org/doi/full/10....
@shematologist.medsky.social @bloodman.bsky.social
jamanetwork.com/journals/jam...
www.nejm.org/doi/full/10....
@shematologist.medsky.social @bloodman.bsky.social
Sunset & snow makes for good hunting.#springbreak
March 25, 2025 at 2:14 AM
Sunset & snow makes for good hunting.#springbreak
I would be the second to last one 😂
March 20, 2025 at 1:09 AM
I would be the second to last one 😂
Reposted by Dr.Uma Borate The Ohio State University / James Cancer Hospital
a very nice review in AJH on considerations of MPN management in women!
onlinelibrary.wiley.com/doi/full/10....
onlinelibrary.wiley.com/doi/full/10....
March 18, 2025 at 3:23 PM
a very nice review in AJH on considerations of MPN management in women!
onlinelibrary.wiley.com/doi/full/10....
onlinelibrary.wiley.com/doi/full/10....
👇🏾
March 19, 2025 at 7:22 PM
👇🏾
Reposted by Dr.Uma Borate The Ohio State University / James Cancer Hospital
Could adjusting a simple blood test reference range save patients unnecessary stress?
Recent research highlights Duffy null-associated neutrophil count (DANC) and the risk it imposes on certain ancestral backgrounds.
Enroll in the ASH course: bit.ly/duffynull
#HemeSky #Hematology #MedSky
Recent research highlights Duffy null-associated neutrophil count (DANC) and the risk it imposes on certain ancestral backgrounds.
Enroll in the ASH course: bit.ly/duffynull
#HemeSky #Hematology #MedSky
March 19, 2025 at 6:56 PM
Could adjusting a simple blood test reference range save patients unnecessary stress?
Recent research highlights Duffy null-associated neutrophil count (DANC) and the risk it imposes on certain ancestral backgrounds.
Enroll in the ASH course: bit.ly/duffynull
#HemeSky #Hematology #MedSky
Recent research highlights Duffy null-associated neutrophil count (DANC) and the risk it imposes on certain ancestral backgrounds.
Enroll in the ASH course: bit.ly/duffynull
#HemeSky #Hematology #MedSky
Reposted by Dr.Uma Borate The Ohio State University / James Cancer Hospital
The 2025 @castleconnolly.bsky.social Exceptional Women in Medicine is out!🎉This honor celebrates🔝female physicians for their leadership & expertise.
👏 Congrats to the OSUCCCJames Heme honorees:
Jennifer Woyach
Uma Borate @beatalleukemia.bsky.social
Alice Mims
Ashley Rosko
Kami Maddocks
Kerry Rogers
👏 Congrats to the OSUCCCJames Heme honorees:
Jennifer Woyach
Uma Borate @beatalleukemia.bsky.social
Alice Mims
Ashley Rosko
Kami Maddocks
Kerry Rogers
March 12, 2025 at 5:35 PM
The 2025 @castleconnolly.bsky.social Exceptional Women in Medicine is out!🎉This honor celebrates🔝female physicians for their leadership & expertise.
👏 Congrats to the OSUCCCJames Heme honorees:
Jennifer Woyach
Uma Borate @beatalleukemia.bsky.social
Alice Mims
Ashley Rosko
Kami Maddocks
Kerry Rogers
👏 Congrats to the OSUCCCJames Heme honorees:
Jennifer Woyach
Uma Borate @beatalleukemia.bsky.social
Alice Mims
Ashley Rosko
Kami Maddocks
Kerry Rogers
December 5, 2024 at 11:08 AM
Our Friday Scientific Workshop on Real World DCTs in Hematology &AI has a fantastic line up of speakers : clinical trialists ( IIT PIs included) statisticians, pharma sponsors, & regulatory experts discussing all things practical about hematology DCTs - join us ! 👇🏾#ASH24
November 26, 2024 at 7:43 PM
Our Friday Scientific Workshop on Real World DCTs in Hematology &AI has a fantastic line up of speakers : clinical trialists ( IIT PIs included) statisticians, pharma sponsors, & regulatory experts discussing all things practical about hematology DCTs - join us ! 👇🏾#ASH24
go.bsky.app/Avv8xad I made this starter pack for any myeloid malignancy academics to find others - please share & add to this !
November 26, 2024 at 7:29 PM
go.bsky.app/Avv8xad I made this starter pack for any myeloid malignancy academics to find others - please share & add to this !
Reposted by Dr.Uma Borate The Ohio State University / James Cancer Hospital
🩸 CHIP, CCUS, & ICUS quick definitions:
CHIP
- leukemia-associated gene mutation w/ VAF ≥ 2%
- normal blood counts
- no dx of another hematologic malignancy
CCUS = CHIP with ≥ 1 cytopenias
ICUS
≥ 1 cytopenias + 🚫 identifiable mutation
#hemesky #MedSky #IMsky
CHIP
- leukemia-associated gene mutation w/ VAF ≥ 2%
- normal blood counts
- no dx of another hematologic malignancy
CCUS = CHIP with ≥ 1 cytopenias
ICUS
≥ 1 cytopenias + 🚫 identifiable mutation
#hemesky #MedSky #IMsky
ICUS/CCUS/CHIP: basics & beyond - PubMed
Patients presenting with idiopathic cytopenia with non-diagnostic marrow morphology and a normal karyotype pose a diagnostic and therapeutic challenge. Additional diagnostic information from mutation ...
pubmed.ncbi.nlm.nih.gov
November 26, 2024 at 3:57 PM
📢 Don’t miss Ohio State’s 2024 Scarlet and Gray Reception at the National ASH Meeting! 🌟
Network, connect, and celebrate with us. 🗓️ Register now: osu.az1.qualtrics.com/jfe/form/SV_8H…#ASH242#BuckeyePrided#ScarletAndGrayay
Network, connect, and celebrate with us. 🗓️ Register now: osu.az1.qualtrics.com/jfe/form/SV_8H…#ASH242#BuckeyePrided#ScarletAndGrayay
November 26, 2024 at 3:35 PM
📢 Don’t miss Ohio State’s 2024 Scarlet and Gray Reception at the National ASH Meeting! 🌟
Network, connect, and celebrate with us. 🗓️ Register now: osu.az1.qualtrics.com/jfe/form/SV_8H…#ASH242#BuckeyePrided#ScarletAndGrayay
Network, connect, and celebrate with us. 🗓️ Register now: osu.az1.qualtrics.com/jfe/form/SV_8H…#ASH242#BuckeyePrided#ScarletAndGrayay